Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Accounts Payables (2011 - 2026)

Palatin Technologies' (PTN) quarterly Accounts Payables came in at $1.7 million in Q1 2026, down 78.21% on a YoY basis from $7.8 million in Q1 2025, and down 68.95% quarter-over-quarter from $5.5 million in Q4 2025.

Analysis

Palatin Technologies (PTN) Accounts Payables (2011 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Accounts Payables for 15 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Accounts Payables fell 78.21% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (down 78.21% YoY), and the FY2025 full-year result was $7.0 million, up 70.62% from the prior year.
  • Accounts Payables fell to $1.7 million in Q1 2026 per PTN's latest filing, from $5.5 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $7.8 million in Q1 2025 and bottomed at $820304.0 in Q4 2022.
  • Historically, Accounts Payables has averaged $4.0 million across 5 years, with a median of $3.8 million in 2022.
  • The sharpest annual moves came in 2022 and 2026: Accounts Payables jumped 412.11% in 2022, then slumped 78.21% in 2026.
  • Over 5 years, Accounts Payables stood at $820304.0 in 2022, then jumped by 94.25% to $1.6 million in 2023, then jumped by 321.61% to $6.7 million in 2024, then fell by 18.83% to $5.5 million in 2025, then slumped by 68.95% to $1.7 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $1.7 million, $5.5 million, and $7.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.16 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.52 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 167.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 108.02 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 403.90 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 25.08 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn - 1.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.69 Mn
Dec 31, 2025 5.45 Mn
Sep 30, 2025 7.41 Mn
Jun 30, 2025 7.00 Mn
Mar 31, 2025 7.77 Mn
Dec 31, 2024 6.72 Mn
Sep 30, 2024 3.95 Mn
Jun 30, 2024 4.10 Mn
Mar 31, 2024 3.44 Mn
Dec 31, 2023 1.59 Mn
Sep 30, 2023 2.27 Mn
Jun 30, 2023 4.30 Mn
Mar 31, 2023 2.79 Mn
Dec 31, 2022 820,304.00
Sep 30, 2022 3.77 Mn
Jun 30, 2022 3.16 Mn
Mar 31, 2022 2.40 Mn
Dec 31, 2021 160,180.00
Sep 30, 2021 762,817.00
Jun 30, 2021 640,650.00